Drug Supply Watch (Malaysia): Malaysia’s health ministry says medicine stocks remain stable, tracking 702 medicine types; as of May 8, 72% are low-risk with over 90 days’ supply, while 118 items are high-risk—though most “critical” medicines still exceed 90 days. Clinical Breakthrough (Hearing Loss): A Phase 2a study suggests ACOU085 may reduce worsening of cisplatin-induced hearing loss in testicular cancer patients. Sleep & Heart Risk: Research presented at SLEEP 2026 links excessive daytime sleepiness plus trouble falling asleep with a more than threefold higher risk of developing hypertension. Access Gap (Sleep Apnea): Rural patients at high risk for OSA are less likely to be referred for evaluation after primary care visits. Menopause Sleep Care: Experts urge clinicians to ask about sleep early and often; elinzanetant appears to improve sleep beyond hot-flash reduction. Pharma Business (Licensing): Dimerix signs an exclusive license for DMX-200 across Greater China, Korea, and parts of Southeast Asia, with major upfront and milestone payments. Regulation (US-UK): FDA and MHRA expand formal liaison collaboration on devices, AI, and innovative medicines. Healthcare Operations (Infection Control): A quality initiative finds hands-on urinary catheter training can cut CAUTIs after a shift to virtual competency checks. Policy (India Exam Integrity): India temporarily blocks Telegram until June 22 to curb alleged cheating ahead of the NEET re-exam. Mental Health Research (Psilocybin): USC launches a psilocybin trial exploring whether mindfulness training can enhance therapy outcomes.